Log in
Register|
pharmwhiz ☆ 2007-09-19 16:02 (6854 d 16:01 ago) Posting: # 1094 Views: 4,114 |
|
|
Hi all, Can any body say is there any specific issues in designing a protocol for delayed release orally dispersible drug? • Is there any point to be borne in mind while designing the BE protocol? • Is single dose replicate fasting study essential? • How will you manage if the drug is highly variable – if it exhibits non linear PK • Can multi-dose studies be conducted? Thanks in advance & best regards pharmwhiz  |
|
chirayu ☆ 2007-10-09 09:53 (6834 d 22:11 ago) (edited on 2007-10-09 11:59) @ pharmwhiz Posting: # 1164 Views: 3,280 |
|
|
hi all, please tell me is formulation like "enteric coated orally dispersible tablet" possible? I am confusing with type of formulation. with Regards chirayu shah -- Edit: Full quote removed. Please see this post! [Jaime] |
|
Helmut ★★★   Vienna, Austria, 2007-10-09 17:10 (6834 d 14:53 ago) @ chirayu Posting: # 1166 Views: 3,314 |
|
|
Hi Chirayu! ❝ ... formulation like "enteric coated orally dispersible tablet" ...  — Dif-tor heh smusma 🖖🏼 Довге життя Україна! ![[image]](https://static.bebac.at/pics/Blue_and_yellow_ribbon_UA.png) Helmut Schütz ![[image]](https://static.bebac.at/img/CC by.png) The quality of responses received is directly proportional to the quality of the question asked. 🚮 Science Quotes |
Ing. Helmut Schütz